DGFT reviews pharma-grade sugar export quota allocation

Pharma-grade sugar exporters must submit quota-use evidence within 10 days

Change
DGFT directed exporters allocated pharma-grade sugar export quota to submit utilisation certificates and additional-allocation requests within 10 days as part of a quota review and reallocation exercise.
Why it matters
The notice turns unused pharma-grade sugar export quota into a time-bound compliance decision for exporters. Exporters that fail to prove utilisation or submit valid contracts and purchase orders risk losing unutilised quota to the common pool for reallocation.
Implications
  • Exporters allocated pharma-grade sugar quota must submit a Chartered Accountant utilisation certificate through the DGFT IT system within 10 days of the notice — failure risks reallocation of unutilised quota.
  • Exporters seeking additional pharma-grade sugar allocation must submit justification and copies of valid export contracts or purchase orders where available — incomplete or late applications will not be considered.
  • Exporters with less than 50% quota utilisation must provide valid export contracts or purchase orders to prevent the unutilised quantity being transferred to the common pool for reallocation.

Full decision brief

See the decision layer

Use 1 free preview to unlock implications, who’s affected, what to watch, and Clarify for this brief.

2 free previews left this month · Resets 1 Jun

Source
Clarify with AI

Clarify unlocks with the decision layer.

Clarify with AI — Pro only

You asked:

Clarify turns any brief into answers specific to your role and exposure.

Pro includes

Implications — what this change may force you to review
Who is affected — which people, workflows, or obligations are touched
What to watch — dates, deadlines, and triggers that matter next
Real-time alerts — delivered when a decision-forcing change is published
Clarify with AI — ask what this change means for you

$29/month · Founding rate, locked for life. Cancel anytime.

Start your trial to clarify this brief

You asked:

Clarify is part of Pro. Start a 14-day trial for full access to every brief, unlimited Clarify questions, and real-time alerts.

Pro includes

Implications — what this change may force you to review
Who is affected — which people, workflows, or obligations are touched
What to watch — dates, deadlines, and triggers that matter next
Real-time alerts — delivered when a decision-forcing change is published
Clarify with AI — ask what this change means for you

$29/month after trial. No credit card required. Cancel anytime.